| The effects of the health system response to the COVID-19 pandemic on chronic disease management: a narrative review T Kendzerska, DT Zhu, AS Gershon, JD Edwards, C Peixoto, R Robillard, ... Risk management and healthcare policy, 575-584, 2021 | 270 | 2021 |
| A scoping review of global vaccine certificate solutions for COVID-19 SS Mithani, AB Bota, DT Zhu, K Wilson Human vaccines & immunotherapeutics 18 (1), 1-12, 2022 | 46 | 2022 |
| Reporting on the opioid crisis (2000–2018): role of The Globe and Mail, a Canadian English-language newspaper in influencing public opinion AML Quan, LA Wilson, SS Mithani, DT Zhu, AB Bota, K Wilson Harm Reduction Journal 17, 1-11, 2020 | 22 | 2020 |
| The emerging fentanyl–xylazine syndemic in the USA: challenges and future directions DT Zhu, J Friedman, P Bourgois, F Montero, S Tamang The Lancet 402 (10416), 1949-1952, 2023 | 20 | 2023 |
| Long-term associations between disaster-related home loss and health and well-being of older survivors: nine years after the 2011 Great East Japan earthquake and tsunami K Shiba, H Hikichi, SS Okuzono, TJ VanderWeele, M Arcaya, A Daoud, ... Environmental health perspectives 130 (7), 077001, 2022 | 20 | 2022 |
| Trends in all‐cause mortality and inpatient and outpatient visits for ambulatory care sensitive conditions during the first year of the COVID‐19 pandemic: a population‐based study T Kendzerska, DT Zhu, M Pugliese, D Manuel, M Sadatsafavi, M Povitz, ... Journal of Hospital Medicine 17 (9), 726-737, 2022 | 17 | 2022 |
| Public health impact and harm reduction implications of xylazine-involved overdoses: a narrative review DT Zhu Harm Reduction Journal 20 (1), 131, 2023 | 16 | 2023 |
| A scoping review of active, participant-centred, digital adverse events following immunization (AEFI) surveillance: a Canadian immunization research network study A Psihogios, AB Bota, SS Mithani, D Greyson, DT Zhu, SG Fung, ... Vaccine 40 (31), 4065-4080, 2022 | 14 | 2022 |
| Promises and perils of the FDA's over-the-counter naloxone reclassification DT Zhu, S Tamang, K Humphreys The Lancet Regional Health–Americas 23, 2023 | 6 | 2023 |
| The barriers, facilitators and association of vaccine certificates on COVID-19 vaccine uptake: a scoping review DT Zhu, M Serhan, SS Mithani, D Smith, J Ang, M Thomas, K Wilson Globalization and Health 19 (1), 73, 2023 | 5 | 2023 |
| Public health and clinical implications of Dobbs v. Jackson for patients and healthcare providers: A scoping review DT Zhu, L Zhao, T Alzoubi, N Shenin, T Baskaran, J Tikhonov, C Wang Plos one 19 (3), e0288947, 2024 | 4 | 2024 |
| Disparities in cancer mortality among disaggregated Asian American subpopulations, 2018–2021 DT Zhu, A Lai, A Park, A Zhong, S Tamang Journal of Racial and Ethnic Health Disparities, 1-23, 2024 | 3 | 2024 |
| Multiple myeloma incidence and mortality trends in the United States, 1999–2020 DT Zhu, A Park, A Lai, L Zhang, H Attar, TR Rebbeck Scientific Reports 14 (1), 14564, 2024 | 3 | 2024 |
| Disaggregating Asian-American Mortality in Drug-Related Overdoses and Behavioral Disorders: A Cross-Sectional Study DT Zhu, A Zhong, WJ Ho, S Tamang Journal of Racial and Ethnic Health Disparities, 1-9, 2024 | 3 | 2024 |
| The global impact of vaccine certificates on COVID-19 vaccine uptake: a scoping review DT Zhu, SS Mithani, D Smith, K Wilson | 3 | 2023 |
| Oral diseases in Palestine DT Zhu, K Zinszer, S Abuzerr The Lancet 404 (10447), 26-27, 2024 | 2 | 2024 |
| Public attitudes towards COVID-19 vaccine mandates and vaccine certificates in Canada: a time series study DT Zhu, S Hawken, M Serhan, F Graves, J Smith, K Wilson Archives of Public Health 82 (1), 32, 2024 | 2 | 2024 |
| A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization … M Serhan, A Psihogios, N Kabir, AB Bota, SS Mithani, DP Smith, DT Zhu, ... Human Vaccines & Immunotherapeutics 20 (1), 2293550, 2024 | 2 | 2024 |
| The influence of sociodemographic factors on COVID-19 vaccine certificate acceptance: A cross-sectional study D Smith, DT Zhu, S Hawken, AB Bota, SS Mithani, A Marcon, ... Human Vaccines & Immunotherapeutics 19 (2), 2220628, 2023 | 2 | 2023 |
| Comparing the use of a mobile app and a web-based notification platform for surveillance of adverse events following influenza immunization: randomized controlled trial AB Bota, JA Bettinger, S Sarfo-Mensah, J Lopez, DP Smith, KM Atkinson, ... JMIR Public Health and Surveillance 9, e39700, 2023 | 2 | 2023 |
Kumanan WilsonBruyère Research Institute, Ottawa Hospital Research Institute, University of OttawaAdresse e-mail validée de ohri.ca
